Healthcare Infection Control Practices Advisory Committee (HICPAC), 3256 [E8-779]

Download as PDF 3256 Federal Register / Vol. 73, No. 12 / Thursday, January 17, 2008 / Notices or the offices of the Board of Governors not later than February 1, 2008. A. Federal Reserve Bank of San Francisco (Tracy Basinger, Director, Regional and Community Bank Group) 101 Market Street, San Francisco, California 94105–1579: 1. NHB Holdings, Inc., and Proficio Mortgage Ventures, LLC, both of Jacksonville, Florida; to engage de novo through its subsidiary, The MIGroup Mortgage Resources, Whippany, New Jersey, in conducting mortgage banking activities, pursuant to section 225.28(b)(1) of Regulation Y. Board of Governors of the Federal Reserve System, January 14, 2008. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E8–787 Filed 1–16–08; 8:45 am] BILLING CODE 6210–01–S postmarked after this date will be considered to the extent practicable. ADDRESSES: Further information, including an electronic copy of the draft EA and other supporting NEPA documents, may be found on the following Web site, https://www.gsa.gov/ kansascityplant. Comments, or requests for copies of the draft EA, should be sent to Carlos Salazar, General Services Administration, 1500 East Bannister Road, Room 2191 (6PTA), Kansas City, MO 64131. Comments may also be e-mailed to NNSA-KC@gsa.gov. Requests for copies of the draft EA may also be made by calling 816–823– 2305 or via e-mail to NNSA-KC@gsa.gov. Carlos Salazar, Regional NEPA Coordinator, GSA Public Buildings Service, Heartland Region. [FR Doc. E8–797 Filed 1–16–08; 8:45 am] Specialist, HICPAC, Division of Healthcare Quality Promotion, NCPDCID, CDC, l600 Clifton Road, NE., Mailstop A–45, Atlanta, Georgia 30333. Telephone (404) 639–1526. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: January 11, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E8–779 Filed 1–16–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration BILLING CODE 6820–14–P Anti-Infective Drugs Advisory Committee; Notice of Meeting GENERAL SERVICES ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES [PBS–N03] Extension of Comment Period of the Draft Environmental Assessment and Wetland Involvement for the Transformation of Facilities and Infrastructure for the Non-Nuclear Production Activities Conducted at the National Nuclear Security Administration’s Kansas City Plant at Kansas City, MO General Services Administration and National Nuclear Security Administration, Department of Energy. ACTION: Notice of extension of comment period. mstockstill on PROD1PC66 with NOTICES AGENCY: SUMMARY: On Monday, December 10, 2007, the General Services Administration (GSA) and National Nuclear Security Administration (NNSA), Department of Energy (DOE) published a Notice of Availability of the Draft Environmental Assessment for the Transformation of Facilities and Infrastructure for the Non-Nuclear Production Activities conducted at the National Nuclear Security Administration’s Kansas City Plant at Kansas City, Missouri, (72 FR 69690) and announced a public comment period ending Monday, January 14, 2008. In the interest of maximizing public participation, GSA and NNSA are extending the public comment period until Wednesday, January 30, 2008. Comments should be submitted to GSA no later than Wednesday, January 30, 2008. Comments DATES: VerDate Aug<31>2005 20:16 Jan 16, 2008 Jkt 214001 Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned committee: Times and Dates: 8 a.m.–5 p.m., February 11, 2008. 8 a.m.–4 p.m., February 12, 2008. Place: Centers for Disease Control and Prevention (CDC), 1600 Clifton Road, Atlanta, Georgia 30333, Global Communications Center, Bldg 19, Auditorium B3. Status: Open to the public, limited only by the space available. Purpose: The Committee is charged with providing advice and guidance to the Secretary, the Assistant Secretary for Health, the Director, CDC, and the Director, National Center for Preparedness, Detection, and Control of Infectious Diseases, regarding (1) the practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters To Be Discussed: Agenda items will include: Urinary Tract Infection Guidelines and Norvirus Guidelines. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Angela B. Scott, Committee Management PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Anti-Infective Drugs Advisory Committee. General Function of the Committee: To provide advice and recommendations to the agency on FDA’s regulatory issues. Date and Time: The meeting will be held on April 1 and 2, 2008, from 8 a.m. to 5 p.m. Location: Sheraton College Park Hotel, The Ballroom, 4095 Powder Mill Rd., Beltsville, MD. The hotel telephone number is 301–937–4422. Contact Person: Sohail Mosaddegh, Center for Drug Evaluation and Research, Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301–827– 7001, FAX: 301–827–6776, e-mail: sohail.mosaddegh@fda.hhs.gov, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), code 3014512530. Please call the Information Line for up-to-date information on this meeting. A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the agency’s Web E:\FR\FM\17JAN1.SGM 17JAN1

Agencies

[Federal Register Volume 73, Number 12 (Thursday, January 17, 2008)]
[Notices]
[Page 3256]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-779]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting for the aforementioned 
committee:

    Times and Dates: 8 a.m.-5 p.m., February 11, 2008. 8 a.m.-4 
p.m., February 12, 2008.
    Place: Centers for Disease Control and Prevention (CDC), 1600 
Clifton Road, Atlanta, Georgia 30333, Global Communications Center, 
Bldg 19, Auditorium B3.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with providing advice and 
guidance to the Secretary, the Assistant Secretary for Health, the 
Director, CDC, and the Director, National Center for Preparedness, 
Detection, and Control of Infectious Diseases, regarding (1) the 
practice of hospital infection control; (2) strategies for 
surveillance, prevention, and control of infections (e.g., 
nosocomial infections), antimicrobial resistance, and related events 
in settings where healthcare is provided; and (3) periodic updating 
of guidelines and other policy statements regarding prevention of 
healthcare-associated infections and healthcare-related conditions.
    Matters To Be Discussed: Agenda items will include: Urinary 
Tract Infection Guidelines and Norvirus Guidelines.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Angela B. Scott, Committee 
Management Specialist, HICPAC, Division of Healthcare Quality 
Promotion, NCPDCID, CDC, l600 Clifton Road, NE., Mailstop A-45, 
Atlanta, Georgia 30333. Telephone (404) 639-1526.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: January 11, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. E8-779 Filed 1-16-08; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.